Pricing Log in Create free account
Friday 6 November 2026 Export XRAY’s income statement to Excel — free account

DENTSPLY SIRONA Inc.

XRAY Healthcare Medical Instruments & Supplies

DENTSPLY SIRONA Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.7 billion, down 2.98% from fiscal 2024.

Revenue
−7.52%
EPS
+99.5%
Free cash flow
−18.0%
Total debt
−1.59%

Quarter to September 2026, against a year earlier

9.56 0.53 −5.25%
Market cap
$2.0B
P/E
0.0×
Fwd P/E
24.5×
Dividend yield
1.59%
F-score
6/9
Altman Z
0.50
Beneish M
−3.03
Dividend safety
22/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

DENTSPLY SIRONA Inc. (XRAY) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, DENTSPLY SIRONA Inc. (XRAY) trades at a EV/EBITDA of 9.3×. Over the past ten years it has ranged from 8.5× (October 2026) to 41.7× (December 2018); the current reading is higher than 3% of that period. That is below the Medical Instruments & Supplies industry median of 14.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 8.7× (59.01%)
FY2024 21.3× 29.58%
FY2023 16.4× 11.59%
FY2022 14.7× 2.04%
FY2021 14.4× (45.93%)
FY2020 26.7× 32.07%
FY2019 20.2× (2.82%)
FY2018 20.8× (49.25%)
FY2017 41.0× 115.25%
FY2016 19.0× 3.38%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 8.7× (8.28%)
Jun 2026 9.5× (17.98%)
Mar 2026 11.6× 32.81%
Dec 2025 8.7× (51.45%)
43 more quarters

Against its own ten years

Low 8.5× High 41.7×
Ten-year median 18.4×
Current reading's percentile 3

EV/EBITDA against peers

Company EV/EBITDA
PLSE Pulse Biosciences, Inc compare n/m
KMTS Kestra Medical Technologies, Ltd. compare n/m
XRAY DENTSPLY SIRONA Inc. 9.3×
STVN Stevanato Group S.p.A. compare 11.3×
LMAT LeMaitre Vascular, Inc. compare 18.9×
STAA STAAR Surgical Company compare 50.1×
WRBY Warby Parker Inc. compare 50.2×
AZTA Azenta, Inc. compare 50.5×
ATRC AtriCure, Inc. compare 83.7×
Medical Instruments & Supplies industry median 14.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on XRAY